vs
Side-by-side financial comparison of Park Hotels & Resorts Inc. (PK) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Park Hotels & Resorts Inc. is the larger business by last-quarter revenue ($629.0M vs $622.0M, roughly 1.0× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs -32.6%, a 67.0% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 0.6%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -0.8%).
Park Hotels & Resorts is an American real estate investment trust (REIT) focused on hotel properties, based in Tysons, Virginia. It was formed in 2017 as a spin-off from Hilton Worldwide.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
PK vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $629.0M | $622.0M |
| Net Profit | $-205.0M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | -26.1% | 62.4% |
| Net Margin | -32.6% | 34.4% |
| Revenue YoY | 0.6% | 4.8% |
| Net Profit YoY | -410.6% | 2.9% |
| EPS (diluted) | $-1.04 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $629.0M | $622.0M | ||
| Q3 25 | $610.0M | $609.3M | ||
| Q2 25 | $672.0M | $578.7M | ||
| Q1 25 | $630.0M | $568.2M | ||
| Q4 24 | $625.0M | $593.6M | ||
| Q3 24 | $649.0M | $564.7M | ||
| Q2 24 | $686.0M | $537.3M | ||
| Q1 24 | $639.0M | $568.0M |
| Q4 25 | $-205.0M | $214.2M | ||
| Q3 25 | $-16.0M | $288.2M | ||
| Q2 25 | $-5.0M | $30.2M | ||
| Q1 25 | $-57.0M | $238.3M | ||
| Q4 24 | $66.0M | $208.2M | ||
| Q3 24 | $54.0M | $544.0M | ||
| Q2 24 | $64.0M | $102.0M | ||
| Q1 24 | $28.0M | $4.8M |
| Q4 25 | -26.1% | 62.4% | ||
| Q3 25 | 9.7% | 70.1% | ||
| Q2 25 | 9.7% | 36.3% | ||
| Q1 25 | 1.1% | 94.0% | ||
| Q4 24 | 13.3% | 60.9% | ||
| Q3 24 | 14.6% | — | ||
| Q2 24 | 17.6% | 50.2% | ||
| Q1 24 | 14.4% | -13.0% |
| Q4 25 | -32.6% | 34.4% | ||
| Q3 25 | -2.6% | 47.3% | ||
| Q2 25 | -0.7% | 5.2% | ||
| Q1 25 | -9.0% | 41.9% | ||
| Q4 24 | 10.6% | 35.1% | ||
| Q3 24 | 8.3% | 96.3% | ||
| Q2 24 | 9.3% | 19.0% | ||
| Q1 24 | 4.4% | 0.8% |
| Q4 25 | $-1.04 | $0.49 | ||
| Q3 25 | $-0.08 | $0.67 | ||
| Q2 25 | $-0.02 | $0.07 | ||
| Q1 25 | $-0.29 | $0.55 | ||
| Q4 24 | $0.32 | $0.46 | ||
| Q3 24 | $0.26 | $1.21 | ||
| Q2 24 | $0.30 | $0.23 | ||
| Q1 24 | $0.13 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $232.0M | $618.7M |
| Total DebtLower is stronger | $3.9B | $9.0B |
| Stockholders' EquityBook value | $3.1B | $9.7B |
| Total Assets | $7.7B | $19.6B |
| Debt / EquityLower = less leverage | 1.23× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $232.0M | $618.7M | ||
| Q3 25 | $278.0M | $938.9M | ||
| Q2 25 | $319.0M | $631.9M | ||
| Q1 25 | $233.0M | $1.1B | ||
| Q4 24 | $402.0M | $929.0M | ||
| Q3 24 | $480.0M | $950.1M | ||
| Q2 24 | $449.0M | $1.8B | ||
| Q1 24 | $378.0M | $843.0M |
| Q4 25 | $3.9B | $9.0B | ||
| Q3 25 | $3.9B | $8.9B | ||
| Q2 25 | $3.9B | $8.0B | ||
| Q1 25 | $3.9B | $7.6B | ||
| Q4 24 | $3.9B | $7.6B | ||
| Q3 24 | $3.9B | $7.6B | ||
| Q2 24 | $3.9B | $7.6B | ||
| Q1 24 | $3.8B | $6.1B |
| Q4 25 | $3.1B | $9.7B | ||
| Q3 25 | $3.4B | $9.6B | ||
| Q2 25 | $3.4B | $9.5B | ||
| Q1 25 | $3.5B | $9.8B | ||
| Q4 24 | $3.6B | $10.3B | ||
| Q3 24 | $3.8B | $10.3B | ||
| Q2 24 | $3.8B | $9.8B | ||
| Q1 24 | $3.8B | $9.9B |
| Q4 25 | $7.7B | $19.6B | ||
| Q3 25 | $8.8B | $19.3B | ||
| Q2 25 | $8.9B | $18.3B | ||
| Q1 25 | $8.9B | $17.6B | ||
| Q4 24 | $9.2B | $18.2B | ||
| Q3 24 | $9.2B | $18.0B | ||
| Q2 24 | $9.2B | $17.7B | ||
| Q1 24 | $9.1B | $16.1B |
| Q4 25 | 1.23× | 0.92× | ||
| Q3 25 | 1.14× | 0.93× | ||
| Q2 25 | 1.12× | 0.84× | ||
| Q1 25 | 1.11× | 0.78× | ||
| Q4 24 | 1.06× | 0.74× | ||
| Q3 24 | 1.03× | 0.74× | ||
| Q2 24 | 1.03× | 0.78× | ||
| Q1 24 | 1.00× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $105.0M | $827.1M |
| Free Cash FlowOCF − Capex | $-3.0M | — |
| FCF MarginFCF / Revenue | -0.5% | — |
| Capex IntensityCapex / Revenue | 17.2% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $102.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.0M | $827.1M | ||
| Q3 25 | $99.0M | $702.6M | ||
| Q2 25 | $108.0M | $364.0M | ||
| Q1 25 | $86.0M | $596.1M | ||
| Q4 24 | $80.0M | $742.5M | ||
| Q3 24 | $140.0M | $703.6M | ||
| Q2 24 | $117.0M | $658.2M | ||
| Q1 24 | $92.0M | $664.6M |
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $31.0M | — | ||
| Q2 25 | $65.0M | — | ||
| Q1 25 | $9.0M | — | ||
| Q4 24 | $17.0M | — | ||
| Q3 24 | $97.0M | — | ||
| Q2 24 | $66.0M | — | ||
| Q1 24 | $22.0M | — |
| Q4 25 | -0.5% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 9.7% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 14.9% | — | ||
| Q2 24 | 9.6% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 17.2% | — | ||
| Q3 25 | 11.1% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 11.0% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 1.21× | 3.57× | ||
| Q3 24 | 2.59× | 1.29× | ||
| Q2 24 | 1.83× | 6.45× | ||
| Q1 24 | 3.29× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PK
| Occupancy | $371.0M | 59% |
| Food And Beverage | $173.0M | 28% |
| Ancillary Hotel | $61.0M | 10% |
| Hotel Other | $24.0M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
